Colorectal Cancer Dataset in Xijing Hospital From 2011
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
Prognostic Cancer Model|Chemotherapy|Nutrition Related Cancer
overall survival, to dead or lost to follow, from date of diagnosis until the date of death from any cause, assessed up to 120 months|DFS, disease-free survival, from date of diagnosis until the first documented progression or recurrence, assessed up to 120 months
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.